Analysis for MS
- 📈 Growth — 28/30
- 💰 Profitability — 18/20
- 🏦 Financial Health — 12/20
- 💵 Valuation — 14/20
- ⚠️ Risk — 7/10
Summary:
📈 Growth & Financial Trajectory
From 2024 Q1 to 2026 Q1, Morgan Stanley's observed quarterly revenues rose from about $15.14B to $20.58B, while net income increased from about $3.46B to $5.64B. Over 8 quarters, this yields roughly +36% revenue growth and +63% net income growth. The operating margin expanded from about 29% to about 34%, signaling stronger operating leverage despite cyclicality.
💰 Margins & Cash Flow
Operating margins improved as revenues rose and cost efficiency modestly improved. Cash flow from operations fluctuated through negative quarters but turned positive by late 2025 and into 2026, aided by financing activity. Net cash flow, continuing, shows resilience with sizable financing inflows supporting liquidity.
🛡️ Balance Sheet & Liquidity
Balance sheet shows durable liquidity but high leverage: long-term debt sits around $270B–$363B with equity near $100B–$115B, resulting in a debt-to-equity around ~3x. Current assets vs current liabilities run near parity to modest excess, implying limited cushion in stressed markets. Cash flow signals a strategic reliance on financing to support liquidity.
⚠️ Key Drivers & Risks
- Drivers: AI/Data Center demand, market activity, wealth management.
- Risks: Cyclicality, high leverage/interest-rate sensitivity, regulatory/compliance exposure.